Bone Marrow Research / 2014 / Article / Tab 1

Research Article

Angiogenesis and Proliferation Index in Patients with Acute Leukemia: A Prospective Study

Table 1

Patient and control group characteristics.

Patients with AML ( )Patients with ALL ( )Control group ( )

Age in years (median (range))32 (14–65)26 (13–66)32 (13–60)
Sex (males/females)15/1118/119/10
*Immunophenotypic distribution of acute leukemia cases4M0, 2M1, 10M2, 3APML, 1M4, 2M5, 2M6, 2M7T-ALL = 13
B-ALL = 16
Not applicable
Hb g/dL (median (range))6.5 (3.1–12.9)6.5 (2.7–13.8)11 (6.5–14)
TLC per cumm (median (range))27,150
(900–2.48 lakh)
37,250
(1,200–5.02 lakh)
8000 (6,000–14,000)
Platelet per cumm (median (range))34,000
(4000–5.21 lakhs)
27,500
(11,000–3.77 lakhs)
1.7 lakhs
(1.3–3 lakhs)
Peripheral blood blast % (median (range))71.5 (1–96)82.5 (1–97)NIL
Subleukemic cases % ( ) 17.86% (5)16.67% (5)NA
Bone marrow cellularityHypercellular = 25
Myelonecrosis = 1
Hypercellular = 29Normal for age
Bone marrow aspirate blast % (median (range))77 (23–96)91 (52–98)Nil

M0: AML with minimal differentiation, M1: AML without maturation, M2: AML with maturation, APML: acute promyelocytic leukemia, M4-Acute myelomonocytic leukemia, M5-Acute monoblastic and monocytic leukemia, M6: acute erythroid leukemia, M7: acute megakaryoblastic leukemia, B-ALL: B acute lymphoblastic leukemia, and T-ALL: T acute lymphoblastic leukemia.